- Home
- NECB vs VYGR Comparison
NECB vs VYGR Comparison
Compare NECB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NECB
- VYGR
- Stock Information
- Founded
- NECB 1934
- VYGR 2013
- Country
- NECB United States
- VYGR United States
- Employees
- NECB N/A
- VYGR N/A
- Industry
- NECB Savings Institutions
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- NECB Finance
- VYGR Health Care
- Exchange
- NECB Nasdaq
- VYGR Nasdaq
- Market Cap
- NECB 295.3M
- VYGR 222.9M
- IPO Year
- NECB N/A
- VYGR 2015
- Fundamental
- Price
- NECB $22.57
- VYGR $4.07
- Analyst Decision
- NECB
- VYGR Strong Buy
- Analyst Count
- NECB 0
- VYGR 10
- Target Price
- NECB N/A
- VYGR $15.75
- AVG Volume (30 Days)
- NECB 49.7K
- VYGR 352.2K
- Earning Date
- NECB 04-24-2025
- VYGR 03-11-2025
- Dividend Yield
- NECB 2.85%
- VYGR N/A
- EPS Growth
- NECB 7.83
- VYGR N/A
- EPS
- NECB 3.58
- VYGR N/A
- Revenue
- NECB $105,835,000.00
- VYGR $80,001,000.00
- Revenue This Year
- NECB $1.50
- VYGR N/A
- Revenue Next Year
- NECB $8.02
- VYGR $23.46
- P/E Ratio
- NECB $6.38
- VYGR N/A
- Revenue Growth
- NECB 6.02
- VYGR N/A
- 52 Week Low
- NECB $14.77
- VYGR $3.56
- 52 Week High
- NECB $31.72
- VYGR $10.66
- Technical
- Relative Strength Index (RSI)
- NECB 39.95
- VYGR 38.31
- Support Level
- NECB $21.31
- VYGR $3.56
- Resistance Level
- NECB $22.91
- VYGR $4.32
- Average True Range (ATR)
- NECB 0.63
- VYGR 0.22
- MACD
- NECB -0.02
- VYGR 0.05
- Stochastic Oscillator
- NECB 50.60
- VYGR 66.45
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. They conduct their activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.